Literature DB >> 6639351

Occupational handling of cytostatic drugs.

B Kolmodin-Hedman, P Hartvig, M Sorsa, K Falck.   

Abstract

The bacterial fluctuation test and measurement of the frequency of sister chromatid exchanges were used for evaluation of the exposure of different groups of hospital personnel to cytostatic drugs. Increased mutagenic activity in the urine was detected only in personnel working with inadequate safety precautions, e.g., lack of a ventilated safety cabin for preparation of parenteral solutions. Although such a safety cabin was used within the hospital pharmacy, increased mutagenic activity was detected in the urine of prescriptionists preparing parenteral cytostatic drugs. After a change of glove material and improvement of ventilation in the safety cabin, no work-related increase in urinary mutagenic activity was seen. None of the different groups tested, showed any increase in the frequency of sister chromatid exchanges. It is therefore concluded that handling of cytostatic drugs according to the issued safety recommendations including working in a well ventilated safety cabin, will not result in any enhancement of mutagenic activity in the urine related to work.

Mesh:

Substances:

Year:  1983        PMID: 6639351     DOI: 10.1007/BF00277812

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  22 in total

1.  Precautions followed by personnel involved with the preparation of parenteral antineoplastic medications.

Authors:  M P Tortorici
Journal:  Hosp Pharm       Date:  1980-06

2.  [Precautionary measures during preparation and infusion of cytostatics].

Authors:  S Gundersen
Journal:  Tidsskr Nor Laegeforen       Date:  1976-09-20

3.  Biologic monitoring of exposure to chemical mutagens in the occupational environment.

Authors:  M Sorsa; K Hemminki; H Vainio
Journal:  Teratog Carcinog Mutagen       Date:  1982

4.  Mutagenicity in urine of nurses handling cytostatic drugs.

Authors:  K Falck; P Gröhn; M Sorsa; H Vainio; E Heinonen; L R Holsti
Journal:  Lancet       Date:  1979-06-09       Impact factor: 79.321

5.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test.

Authors:  B N Ames; J Mccann; E Yamasaki
Journal:  Mutat Res       Date:  1975-12       Impact factor: 2.433

6.  Mutagenicity in urine of workers in rubber industry.

Authors:  K Falck; M Sorsa; H Vainio; I Kilpikari
Journal:  Mutat Res       Date:  1980-09       Impact factor: 2.433

7.  Mutagenic activity in photocopies.

Authors:  G Löfroth; E Hefner; I Alfheim; M Møoller
Journal:  Science       Date:  1980-08-29       Impact factor: 47.728

8.  Handling of injectable antineoplastic agents.

Authors:  R S Knowles; J E Virden
Journal:  Br Med J       Date:  1980-08-30

9.  Simultaneous staining of sister chromatid exchanges and Q-bands in human chromosomes after treatment with methyl methane sulphonate, quinacrine mustard, and quinacrine.

Authors:  U Haglund; L Zech
Journal:  Hum Genet       Date:  1979-07-18       Impact factor: 4.132

10.  Mutagenicity of urine from nurses handling cytostatic drugs, influence of smoking.

Authors:  R P Bos; A O Leenaars; J L Theuws; P T Henderson
Journal:  Int Arch Occup Environ Health       Date:  1982       Impact factor: 3.015

View more
  15 in total

Review 1.  Drugs hazardous to healthcare workers. Evaluation of methods for monitoring occupational exposure to cytostatic drugs.

Authors:  P J Sessink; R P Bos
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 2.  The risks of handling cytotoxic drugs. II. Recommendations for working with cytotoxic drugs.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

Review 3.  The risks of handling cytotoxic drugs. I. Methods of testing exposure.

Authors:  G P Kaijser; W J Underberg; J H Beijnen
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

4.  Evaluation of genotoxic risk of handling cytostatic drugs in clinical pharmacy practice.

Authors:  E P Guinée; G H Beuman; G Hageman; I J Welle; J C Kleinjans
Journal:  Pharm Weekbl Sci       Date:  1991-04-26

5.  Closed hyperthermic intraperitoneal chemotherapy with open abdomen: a novel technique to reduce exposure of the surgical team to chemotherapy drugs.

Authors:  Laurent Benoit; Nicolas Cheynel; Pablo Ortega-Deballon; Giovanni Di Giacomo; Bruno Chauffert; Patrick Rat
Journal:  Ann Surg Oncol       Date:  2007-10-10       Impact factor: 5.344

6.  Urine mutagenicity, chromosomal abnormalities and sister chromatid exchanges in lymphocytes of nurses handling cytostatic drugs.

Authors:  I Stucker; A Hirsch; T Doloy; I Bastie-Sigeac; D Hemon
Journal:  Int Arch Occup Environ Health       Date:  1986       Impact factor: 3.015

7.  Monitoring exposure of hospital personnel handling cytostatic drugs and contaminated materials.

Authors:  M P DeMéo; S Mérono; A D DeBaille; A Botta; M Laget; H Guiraud; G Duménil
Journal:  Int Arch Occup Environ Health       Date:  1995       Impact factor: 3.015

8.  Increasing rates of DNA single-strand breaks in lymphocytes of clinical personnel handling cytostatic drugs.

Authors:  M Reitz; S Afghanyar; P Gutjahr
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

9.  Detection of contamination with antineoplastic agents in a hospital pharmacy department.

Authors:  P J Sessink; R B Anzion; P H Van den Broek; R P Bos
Journal:  Pharm Weekbl Sci       Date:  1992-02-21

10.  Leukaemia and reproductive outcome among nurses handling antineoplastic drugs.

Authors:  T Skov; B Maarup; J Olsen; M Rørth; H Winthereik; E Lynge
Journal:  Br J Ind Med       Date:  1992-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.